Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

348

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2026

Conditions

Arterial Hypertension

Interventions

DRUG

Olmesartan medoxomil 40mg + chlorthalidone 12,5mg

1 tablet a day

DRUG

Olmesartan medoxomil 40mg + chlorthalidone 25mg

1 tablet a day

DRUG

Olmesartan 40mg + Hydrochlorothiazide 12,5mg

1 tablet a day

DRUG

Olmesartan 40mg + Hydrochlorothiazide 25mg

1 tablet a day